Medical Device News Magazine

Compressed SPEEDER Technology for 3D Exams On 1.5T MR, Enabling High-speed MR Imaging Now FDA Approved

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 21, 2020

Compressed SPEEDER technology for 3D exams has been FDA-cleared for 3D sequences on Canon Medical Systems USA, Inc.’s Vantage Orian 1.5T MR system, so clinicians can easily expect to scan at least twice as fast, and even faster in many clinical scenarios*.

Compressed SPEEDER 3D** boosts MRI scan times during 3D sequences for exams such as surgical planning and orthopedic applications by reconstructing full resolution images from under-sampled data through iterative reconstruction. The innovative technique overcomes many of the limitations inherent to traditional parallel imaging and allows for greater acceleration. The system can even further accelerate exams with Fast3D, a new technique that can be used in combination with Compressed SPEEDER 3D to help make exams even quicker.

Compressed SPEEDER technology is available as an option in an all-new new version of M-Power software for the Vantage Orian 1.5T, which is also available with Fat Fraction Quantification**, an application integrated directly onto the system’s console to help clinicians image and quantify fatty liver disease. The application acquires six MR echoes at once, allowing for quick diagnoses, detailed severity grading, disease monitoring and treatment response, all in alignment with QIBA standards.

“With 30 percent of the U.S. population suffering from Fatty Liver Disease, the ability to diagnose quickly as well as quantify and monitor the disease has become extremely important to clinicians. Our Fat Fraction Quantification is an ideal solution, and it is on our Vantage Orian 1.5T console so that it can be integrated into existing workflow,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc.

Furuyama concluded, “At Canon Medical, our priority is to support our customers and their patients by providing them with timely advancements that can impact their outcomes and workflow. With the help of Compressed SPEEDER for 3D exams along with Fat Fraction Quantification, healthcare providers can offer a quick and comfortable experience for their patients.”


* Actual acceleration factors vary by case. Maximum acceleration factor is up to 16 times.

** Compressed SPEEDER 3D and Fat Fraction Quantification are both optional. Fat Fraction Quantification is FI-Quant.

Vantage Orian and Made for life are trademarks of Canon Medical Systems.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”